Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bayer AG ADR | 11 | 0 | 2 | 0 | €8.95 | - | - |
| BB Biotech AG | 1 | 0 | 0 | 0 | €48.65 | - | - |
| Becton, Dickinson & Co. | 11 | 0 | 2 | 0 | €171.15 | €210.90 | 23.225% |
| Biocryst Pharmaceuticals | 21 | 0 | 0 | 0 | €6.45 | €14.65 | 127.051% |
| Biogen Inc. | 26 | 0 | 1 | 0 | €148.35 | €182.33 | 22.907% |
| Bio-Rad Labs Inc. A | 6 | 0 | 0 | 0 | €269.30 | €347.08 | 28.881% |
| Bio-Techne Corp. | 18 | 0 | 2 | 0 | €51.50 | €60.82 | 18.103% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €111.15 | - | - |
| Boston Scientific | 58 | 0 | 2 | 0 | €79.00 | €107.74 | 36.377% |
| Bristol-Myers Squibb | 4 | 2 | 0 | 1 | €44.67 | €59.59 | 33.397% |
| Brookdale Sr Lvg | 9 | 1 | 1 | 0 | €8.60 | €11.20 | 30.227% |
| Bruker Corp. | 16 | 0 | 2 | 0 | €38.44 | €48.54 | 26.276% |
| Capricor Therapeutics Inc | 2 | 0 | 0 | 0 | €22.20 | - | - |
| Catalyst Pharmaceutical Partners Inc | 16 | 0 | 1 | 0 | €20.12 | €29.84 | 48.296% |
| Celldex Therapeutics | 11 | 2 | 0 | 0 | €24.00 | €42.18 | 75.758% |
| Centene Corp. | 18 | 0 | 0 | 0 | €34.80 | €61.30 | 76.147% |
| Cerus Corp. | 1 | 0 | 0 | 0 | €1.85 | €3.82 | 106.282% |
| Charles River Labs Intl | 19 | 0 | 1 | 0 | €164.45 | €165.88 | 0.868% |
| Chemed Corp. | 9 | 0 | 0 | 0 | €362.00 | €515.26 | 42.336% |
| Chimerix Inc. | 3 | 2 | 0 | 0 | €7.52 | €10.56 | 40.390% |
| Chromadex Corp | 9 | 0 | 0 | 0 | €5.55 | €10.10 | 82.065% |
| Cigna Corp. | 42 | 0 | 3 | 0 | €234.00 | €336.78 | 43.923% |
| Clinuvel Pharmaceuticals | 2 | 0 | 0 | 0 | €6.84 | €9.00 | 31.579% |
| Corcept Therapeutics Inc. | 11 | 0 | 1 | 0 | €74.98 | €124.85 | 66.514% |
| CorMedix Inc | 1 | 0 | 1 | 0 | €9.80 | - | - |